Allspring Global Investments Holdings LLC Has $1.47 Million Holdings in USANA Health Sciences, Inc. (NYSE:USNA)

Allspring Global Investments Holdings LLC increased its holdings in shares of USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 14,068.2% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 38,821 shares of the company's stock after purchasing an additional 38,547 shares during the period. Allspring Global Investments Holdings LLC owned 0.20% of USANA Health Sciences worth $1,472,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of USNA. BOKF NA raised its position in shares of USANA Health Sciences by 274.5% in the first quarter. BOKF NA now owns 2,771 shares of the company's stock valued at $133,000 after purchasing an additional 2,031 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in USANA Health Sciences by 9.2% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,849 shares of the company's stock valued at $284,000 after acquiring an additional 494 shares during the period. Exchange Traded Concepts LLC raised its holdings in USANA Health Sciences by 4.4% in the 3rd quarter. Exchange Traded Concepts LLC now owns 7,709 shares of the company's stock valued at $292,000 after acquiring an additional 322 shares during the period. SG Americas Securities LLC acquired a new stake in USANA Health Sciences during the second quarter worth approximately $340,000. Finally, Creative Planning bought a new stake in shares of USANA Health Sciences during the third quarter worth approximately $394,000. Institutional investors and hedge funds own 54.25% of the company's stock.

Analysts Set New Price Targets

USNA has been the topic of a number of recent research reports. DA Davidson lowered their target price on USANA Health Sciences from $38.00 to $35.00 and set a "neutral" rating on the stock in a research note on Wednesday, October 23rd. StockNews.com lowered USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a report on Wednesday, July 24th.

USANA Health Sciences Price Performance

USANA Health Sciences stock traded up $0.20 during midday trading on Thursday, hitting $36.94. The company's stock had a trading volume of 97,661 shares, compared to its average volume of 80,974. The company has a market cap of $703.78 million, a price-to-earnings ratio of 13.05, a PEG ratio of 1.25 and a beta of 0.89. USANA Health Sciences, Inc. has a 1-year low of $34.15 and a 1-year high of $54.81. The company has a 50-day moving average price of $37.74 and a two-hundred day moving average price of $42.25.

USANA Health Sciences (NYSE:USNA - Get Free Report) last released its quarterly earnings results on Tuesday, October 22nd. The company reported $0.56 earnings per share for the quarter, beating analysts' consensus estimates of $0.49 by $0.07. The company had revenue of $200.22 million during the quarter, compared to the consensus estimate of $208.45 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. During the same period in the previous year, the business earned $0.59 earnings per share. Sell-side analysts forecast that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Insider Transactions at USANA Health Sciences

In other USANA Health Sciences news, insider Paul A. Jones sold 6,266 shares of the firm's stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $38.38, for a total value of $240,489.08. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, Director Gilbert A. Fuller sold 674 shares of the company's stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $39.69, for a total transaction of $26,751.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Paul A. Jones sold 6,266 shares of USANA Health Sciences stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $38.38, for a total value of $240,489.08. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by insiders.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.